Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Cenerimod by Idorsia Pharmaceutical for Systemic Lupus Erythematosus: Likelihood of Approval
Cenerimod is under clinical development by Idorsia Pharmaceutical and currently in Phase III for Systemic Lupus Erythematosus. According to GlobalData,...